These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 8968425)

  • 1. Nitric oxide influences dopaminergic processes.
    Liu Y
    Adv Neuroimmunol; 1996; 6(3):259-64. PubMed ID: 8968425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dopamine D2 receptor-dependent modulation of striatal NO synthase activity.
    Sammut S; Bray KE; West AR
    Psychopharmacology (Berl); 2007 Apr; 191(3):793-803. PubMed ID: 17206493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modulation of dopamine uptake by nitric oxide in cultured mesencephalic neurons.
    Salum C; Raisman-Vozari R; Michel PP; Gomes MZ; Mitkovski M; Ferrario JE; Ginestet L; Del Bel EA
    Brain Res; 2008 Mar; 1198():27-33. PubMed ID: 18255050
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dose-related alteration in nitric oxide synthase mRNA expression induced by amphetamine and the full D1 dopamine receptor agonist SKF-82958 in mouse striatum.
    Wang JQ; Lau YS
    Neurosci Lett; 2001 Sep; 311(1):5-8. PubMed ID: 11585554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine agonist-induced penile erection and yawning: differential role of D₂-like receptor subtypes and correlation with nitric oxide production in the paraventricular nucleus of the hypothalamus of male rats.
    Sanna F; Succu S; Melis MR; Argiolas A
    Behav Brain Res; 2012 May; 230(2):355-64. PubMed ID: 22391116
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of intracellular dopamine levels by dopaminergic drugs: involvement of vesicular monoamine transporter.
    Izumi Y; Yamamoto N; Kume T; Katsuki H; Sawada H; Akaike A
    Eur J Pharmacol; 2008 Mar; 582(1-3):52-61. PubMed ID: 18261722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of lipopolysaccharide-induced tumor necrosis factor-alpha and nitric oxide production by dopamine receptor agonists and antagonists in mice.
    Haskó G; Szabó C; Merkel K; Bencsics A; Zingarelli B; Kvetan V; Vizi ES
    Immunol Lett; 1996 Mar; 49(3):143-7. PubMed ID: 8739308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopaminergic involvement in the discriminative-stimulus effects of methamphetamine in rats.
    Munzar P; Goldberg SR
    Psychopharmacology (Berl); 2000 Feb; 148(2):209-16. PubMed ID: 10663437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and nitric oxide interaction on the modulation of prepulse inhibition of the acoustic startle response in the Wistar rat.
    Salum C; Guimarães FS; Brandão ML; Del Bel EA
    Psychopharmacology (Berl); 2006 Apr; 185(2):133-41. PubMed ID: 16402193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dopaminergic modulation of nitric oxide synthase activity in subregions of the rat nucleus accumbens.
    Hoque KE; West AR
    Synapse; 2012 Mar; 66(3):220-31. PubMed ID: 22034069
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between nitric oxide and dopaminergic transmission in the peripheral control of penile erection.
    Senbel AM
    Fundam Clin Pharmacol; 2011 Feb; 25(1):63-71. PubMed ID: 20412313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Behavioral effects of cocaine: interactions with D1 dopaminergic antagonists and agonists in mice and squirrel monkeys.
    Katz JL; Kopajtic TA; Myers KA; Mitkus RJ; Chider M
    J Pharmacol Exp Ther; 1999 Oct; 291(1):265-79. PubMed ID: 10490913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release.
    Morris BJ; Simpson CS; Mundell S; Maceachern K; Johnston HM; Nolan AM
    Neuropharmacology; 1997; 36(11-12):1589-99. PubMed ID: 9517430
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurochemical evidence of dopamine release by lateral olivocochlear efferents and its presynaptic modulation in guinea-pig cochlea.
    Gáborján A; Lendvai B; Vizi ES
    Neuroscience; 1999 Apr; 90(1):131-8. PubMed ID: 10188940
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated neuronal nitric oxide synthase expression in chronic haloperidol-treated rats.
    Lau YS; Petroske E; Meredith GE; Wang JQ
    Neuropharmacology; 2003 Dec; 45(7):986-94. PubMed ID: 14573391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A direct dopaminergic control of aromatase activity in the quail preoptic area.
    Baillien M; Balthazart J
    J Steroid Biochem Mol Biol; 1997; 63(1-3):99-113. PubMed ID: 9449211
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide inhibits depolarization-induced release of endogenous dopamine in the rabbit retina.
    Djamgoz MB; Cunningham JR; Davenport SL; Neal MJ
    Neurosci Lett; 1995 Sep; 198(1):33-6. PubMed ID: 8570090
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of D2 agonists by striatal injection on excessive release of dopamine and hyperactivity induced by Bay K 8644 in rats.
    Maruya H; Watanabe Y; Okita M; Lawlor GF; Utsumi H; Niitsuma T
    Neuroscience; 2003; 118(4):1091-8. PubMed ID: 12732253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopamine inhibits melatonin release in the mammalian retina: in vitro evidence.
    Tosini G; Dirden JC
    Neurosci Lett; 2000 Jun; 286(2):119-22. PubMed ID: 10825651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced striatal dopamine DA D2 receptor function in dominant-negative GSK-3 transgenic mice.
    Gomez-Sintes R; Bortolozzi A; Artigas F; Lucas JJ
    Eur Neuropsychopharmacol; 2014 Sep; 24(9):1524-33. PubMed ID: 25088904
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.